ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102 | +64.5% | 207 | +29.4% | 0.00% | – |
| Q2 2023 | $62 | +14.8% | 160 | +10.3% | 0.00% | – |
| Q1 2023 | $54 | -22.9% | 145 | -21.2% | 0.00% | -100.0% |
| Q4 2022 | $70 | -99.9% | 184 | +13.6% | 0.00% | – |
| Q3 2022 | $57,000 | +32.6% | 162 | +42.1% | 0.00% | – |
| Q2 2022 | $43,000 | +152.9% | 114 | +107.3% | 0.00% | – |
| Q1 2022 | $17,000 | +41.7% | 55 | +66.7% | 0.00% | – |
| Q4 2021 | $12,000 | +500.0% | 33 | +450.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |